quinazolines has been researched along with plx 4720 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Debs, BW; Griffiths, AD; Merten, CA; Tschulena, U | 1 |
| Abel, EV; Amaravadi, RK; Aplin, AE; Basile, KJ; Ertel, A; Fortina, P; Karakousis, GC; Kugel, CH; Le, K; Lee, JB; Schuchter, LM; Witkiewicz, AK; Xu, W; Xu, X | 1 |
| Buck, JR; Cheung, YY; Coffey, RJ; Dawson, ES; Hight, MR; Manning, HC; Nickels, ML; Saleh, S; Tang, D; Washington, MK; Zhao, P | 1 |
| Amzallag, A; Baniya, S; Benes, CH; Cooper, ZA; Fisher, DE; Flaherty, KT; Frederick, DT; Friedman, AA; Haber, DA; Hargreaves, L; Igras, V; Lawrence, DP; Piris, A; Pruteanu-Malinici, I; Ramaswamy, S; Wargo, JA | 1 |
| Bekiranov, S; Capaldo, B; Conaway, MR; Gioeli, D; Mackey, AJ; Petricoin, EF; Roller, DG; Weber, MJ | 1 |
5 other study(ies) available for quinazolines and plx 4720
| Article | Year |
|---|---|
A competitive co-cultivation assay for cancer drug specificity evaluation.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluorescence; High-Throughput Screening Assays; Humans; Indoles; Kidney Neoplasms; Organ Specificity; Quinazolines; Reproducibility of Results; Sodium Azide; Sulfonamides; Tyrphostins | 2011 |
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3.
Topics: Cell Survival; Enzyme Inhibitors; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Indoles; Lapatinib; MAP Kinase Kinase Kinases; Melanoma; Oligonucleotide Array Sequence Analysis; Phosphorylation; Quinazolines; raf Kinases; Receptor, ErbB-3; Signal Transduction; Skin Neoplasms; Sulfonamides; Transcription, Genetic | 2013 |
A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Colonic Neoplasms; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorobenzenes; Humans; Imidazoles; Immunoblotting; Immunohistochemistry; Indoles; Mice, Inbred C57BL; Mice, Nude; Organophosphates; Peptides; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Quinolines; Radiopharmaceuticals; Sulfonamides; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; High-Throughput Screening Assays; Humans; Indoles; Melanoma; Mice; Molecular Targeted Therapy; Proto-Oncogene Proteins B-raf; Quinazolines; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Xenograft Model Antitumor Assays | 2015 |
Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Humans; Indoles; Lapatinib; MAP Kinase Signaling System; Melanoma; Mice; Mice, Nude; Mice, SCID; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinazolines; Sulfonamides | 2016 |